David E. Lazar - Interim CEO, 10%+ Owner at Cyclacel Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CEO, 10%+ Owner
Stock Symbol
CYCC, CYCCP on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David E. Lazar since 4/22/2024

Holdings reported by David E. Lazar for Cyclacel Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $3.32 Feb 26, 2025 Direct
Series D Convertible Preferred Stock 355K Feb 26, 2025 Direct Common Stock
Series C Convertible Preferred Stock 0 Feb 26, 2025 Direct Common Stock 2.65M

Transactions reported by David E. Lazar for Cyclacel Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.